How can vaccines against influenza and other viral diseases be made more effective?

PLoS Biology

Volumn 8, Issue 12, 2010, Pages

  Nara, Peter L ^a,b   Tobin, Gregory J ^a,b   Ray Chaudhuri, A ^a   Trujillo, Jessie D ^b   Lin, George ^a   Cho, Michael W ^b   Levin, Simon A ^c   Ndifon, Wilfred ^d   Wingreen, Ned S ^c  

^a Biological Mimetics Inc   (United States)

^b IOWA STATE UNIVERSITY   (United States)

^c PRINCETON UNIVERSITY   (United States)

^d WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HEMAGGLUTININ; INFLUENZA VACCINE; VIRUS VACCINE;

ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; ECOLOGY; EPIDEMIC; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INFLUENZA A (H1N1); INFLUENZA A (H5N1); INFLUENZA VACCINATION; MOLECULAR EVOLUTION; MOLECULAR IMPRINTING; PHENOTYPE; PHYLOGENY; SEASONAL VARIATION; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS MUTATION; VIRUS TRANSMISSION; GENETICS; IMMUNOLOGY; ORTHOMYXOVIRUS; VACCINATION; VIRUS INFECTION;

HUMANS; INFLUENZA VACCINES; ORTHOMYXOVIRIDAE; VACCINATION; VIRAL VACCINES; VIRUS DISEASES;

EID: 78650425411     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.1000571     Document Type: Article

References (21)

1. Kohler H, Goudsmit J, Nara P (1992) Clonal antibody dominance in HIV-1 infection: Cause for a limited and failing immune response. J Acquir Immune Defic Syndr 5: 1158-1168.
2. Kohler H, Muller S, Nara P (1994) Deceptive imprinting in the immune response against HIV-1. Immunol Today 13: 475-428.
3. Tobin G, Trujillo J, Bushnell R, Lin G, Chaudhuri R, et al. (2008) Deceptive imprinting and immune refocusing in vaccine design. Vaccine 26: 6189-6199.
4. Ndifon W, Wingreen NS, Levin SA (2009) Differential neutralization efficiency of hemagglutinin epitopes, antibody interference, and the design of influenza vaccines. Proc Natl Acad Sci 106: 8701-8706.
5. Bush RM, Fitch WM, Bender CA, Cox NJ (1999) Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol Biol Evol 16: 1457-1465.
6. Ferguson NM, Galvani AP, Bush RM (2003) Ecological and immunological determinants of influenza evolution. Nature 422: 428-433.
7. Gog JR, Grenfell BT (2002) Dynamics and selection of many-strain pathogens. Proc Natl Acad Sci USA 99: 17209-17214.
8. Koelle K, Cobey S, Grenfell BT, Pascual M (2006) Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science 314: 1898-1903.
9. Levin SA, Dushoff J, Plotkin JB (2004) Evolution and persistence of influenza A and other diseases. Math Biosc 188: 17-28.
10. Ferguson NM, Bush RM (2004) Influenza evolution and immune selection International Congress Series 1263: 12-16.
11. Ben-Yedidia T, Arnon R (2005) Towards an epitope-based human vaccine for influenza. Hum Vaccin 1: 95-101.
12. Ben-Yedidia T (2010) Multimeric-001: Biond- Vax's universal flu vaccine. Expert Rev Vacc 9(3): 241-242.
13. Garrity RR, Rimmelzwaan G, Minassian A, Tsai WP, Lin G, et al. (1997) Refocusing neutralizing antibody response by targeted dampening of an immunodominant epitope. J Immunol 159: 279-289.
14. Nara PL, Garrity R (1998) Deceptive imprinting: a cosmopolitan strategy for complicating vaccination. Vaccine 16(19): 1780-7.
15. Nara PL (1999) Deceptive imprinting: Insights into mechanisms of immune evasion and vaccine development. Adv in Vet Med 41: 115-134.
16. Nara PL, Lin G (2009) Immunodominance, deceptive imprinting and immune refocusing technology. In: Levine MM, Dougan G, Good MF, Liu MA, eds. New Generation Vaccines. NY: Informa Healthcare. pp 191-209.
17. Frank SA (2002) Immunology and Evolution of Infectious Disease. PrincetonNJ: Princeton University Press. 832 p.
18. Francis T, Jr. (1960) On the doctrine of original antigenic sin. Proc of the Am Phil Soc 104(6): 572-578.
19. Pantophlet R, Burton DR (2006) GP120: Target for neutralizing HIV-1 antibodies. Annu Rev Immunol 24: 739-769.
20. Steel J, Lowen AC, Wang TT, Yondola M, Gao Q, et al. (2010) Influenza virus vaccine based on the conserved hemagglutinin stalk domain. mBio 1: e00018-10.
21. Taylor HP, Armstrong SJ, Dimmock NJ (1987) Quantitative relationships between an influenza virus and neutralizing antibody. Virology 159: 288-298.